Given a brain MRI showing symmetric FLAIR (Fluid‑attenuated inversion recovery) hyperintensities in the cerebellum, several periventricular FLAIR lesions, and a juxtacortical lesion in the right parietal lobe without post‑contrast enhancement, and a cervical spine MRI showing a tiny linear intramedullary signal at C4‑C5 likely representing central canal prominence, could these findings indicate demyelinating disease and what diagnostic and management steps should be taken?

Your MRI Findings Are Suggestive of Demyelinating Disease and Require Immediate Diagnostic Workup

Based on your imaging findings—periventricular FLAIR hyperintensities, juxtacortical lesion in the right parietal lobe, symmetric cerebellar involvement, and a cervical cord signal abnormality—you meet several criteria for dissemination in space that are characteristic of multiple sclerosis, and you should proceed urgently with lumbar puncture and follow-up MRI with gadolinium contrast. 1

Why These Findings Matter

Your brain MRI demonstrates lesions in three of the four classic anatomical locations required for MS diagnosis:

• Periventricular lesions (directly touching the lateral ventricles) 1
• Juxtacortical lesion in the right parietal lobe (touching or involving the cortex) 1
• Infratentorial involvement (symmetric cerebellar hyperintensities) 1

The cervical spine finding at C4-C5, while described as "likely central canal prominence," still represents an intramedullary signal abnormality that warrants careful consideration. MS lesions in the cervical cord are present in 80-90% of MS patients and preferentially affect this region. 2, 1

Critical Diagnostic Steps You Need Now

1. Immediate Gadolinium-Enhanced MRI (Within 1-2 Weeks)

The absence of post-contrast enhancement in your initial scan is a significant limitation. You need a repeat brain and complete spine MRI with gadolinium contrast because:

• Enhancement patterns distinguish active inflammatory lesions from chronic plaques 1, 3
• Gadolinium enhancement in MS is typically transient (2-8 weeks, usually 4 weeks) 1
• The presence of enhancing lesions would establish dissemination in time (DIT) and could allow immediate MS diagnosis if you have clinical symptoms 1

The protocol must include: 1, 4

• Brain: T2-FLAIR, T1 pre- and post-gadolinium, susceptibility-weighted imaging (SWI) or T2* sequences
• Complete spine: Cervical AND thoracic cord imaging with T2 and T1 post-gadolinium
• Fat-suppressed sequences if optic nerve involvement is suspected

2. Lumbar Puncture (As Your Radiologist Recommended)

Proceed with CSF analysis looking specifically for:

• Oligoclonal bands (present in ~95% of MS patients) 5
• IgG index elevation
• Cell count and protein (to exclude infection/inflammation)
• Anti-aquaporin-4 (AQP4) antibodies to rule out neuromyelitis optica spectrum disorder (NMOSD) 6, 7, 3
• Anti-MOG antibodies to exclude MOG antibody-associated disease (MOGAD) 6, 7, 3

This is critical because NMOSD and MOGAD can mimic MS but require completely different treatments and have different prognoses. NMOSD typically shows longitudinally extensive spinal cord lesions (≥3 vertebral segments), which you don't have, but antibody testing is mandatory. 3

3. Advanced MRI Sequences for Diagnostic Certainty

If conventional imaging remains equivocal, request: 8, 4, 3

• Susceptibility-weighted imaging (SWI) to look for the "central vein sign" (present in ~95% of MS lesions, highly specific) 8, 4
• Paramagnetic rim lesions on SWI (chronic active lesions specific to MS) 4, 3
• These features achieve 94% diagnostic accuracy at 3T MRI 3

Red Flags That Would Argue AGAINST MS

Your imaging does NOT show these concerning features, which is reassuring: 1

• ❌ Symmetric central pontine involvement (suggests vascular disease)
• ❌ Longitudinally extensive cord lesions ≥3 segments (suggests NMOSD)
• ❌ Tumefactive lesions with mass effect
• ❌ Leptomeningeal enhancement (suggests vasculitis or infection)
• ❌ Cortical laminar necrosis or diffusion restriction (suggests stroke)

However, the symmetric cerebellar involvement is somewhat atypical for MS, which usually shows asymmetric lesion distribution, especially early on. 1 This pattern requires careful exclusion of:

• Toxic/metabolic causes (alcohol, medications, vitamin deficiencies)
• Paraneoplastic syndromes
• Genetic ataxias
• Posterior reversible encephalopathy syndrome (PRES)

What Happens If You Have Clinical Symptoms?

If you've had ANY neurological symptoms (vision changes, numbness, weakness, balance problems, bladder dysfunction) that lasted >24 hours and are consistent with CNS demyelination:

• You already have dissemination in space (3+ anatomical locations) 1, 4
• If the gadolinium-enhanced MRI shows ANY enhancing lesion OR a follow-up MRI in 3-6 months shows new T2 lesions, you meet criteria for MS diagnosis 4, 5
• If you have oligoclonal bands in CSF, this strengthens the diagnosis significantly 5

Age and Vascular Risk Factor Considerations

If you are over 50 years old or have vascular risk factors (hypertension, diabetes, smoking, hyperlipidemia), the diagnostic bar is higher: 1

• More stringent criteria apply—you would need a higher number of periventricular lesions specifically abutting the ventricles
• Small vessel ischemic disease becomes a major differential diagnosis
• The juxtacortical and cerebellar lesions become MORE important diagnostically because vascular lesions typically spare these areas 1

Timeline for Action

Week 1-2:

• Schedule gadolinium-enhanced brain and complete spine MRI
• Perform lumbar puncture with comprehensive CSF analysis including AQP4 and MOG antibodies
• Obtain serum AQP4 and MOG antibodies (more sensitive than CSF for these)

Week 3-4:

• Review all results with a neurologist experienced in demyelinating diseases
• If diagnosis remains uncertain, schedule 3-month follow-up MRI to assess for new lesions (establishes DIT) 9, 1

Month 3-6:

• Repeat MRI if initial workup was inconclusive
• New or enlarging T2 lesions OR new enhancing lesions establish dissemination in time 1, 4

Critical Pitfall to Avoid

Do NOT accept a diagnosis of MS without:

1. Gadolinium-enhanced imaging of brain AND spine 1, 4
2. CSF analysis with oligoclonal bands 5
3. Exclusion of AQP4 and MOG antibody-associated diseases 6, 7, 3
4. Clinical correlation with typical demyelinating symptoms 1

The absence of contrast enhancement in your initial scan means you cannot yet establish dissemination in time, and misdiagnosis of MS occurs in up to 20% of cases when these steps are skipped. 1

Bottom Line

Your imaging pattern is consistent with demyelinating disease affecting multiple CNS regions. The next 2-4 weeks are critical for establishing the correct diagnosis through contrast-enhanced imaging, CSF analysis, and antibody testing. Do not delay these studies, as early accurate diagnosis directly impacts treatment decisions and long-term outcomes. The symmetric cerebellar involvement requires particular attention to exclude MS mimics, but your overall pattern—periventricular, juxtacortical, infratentorial, and possible cord involvement—strongly suggests a demyelinating process that needs definitive characterization now.